It has been suggested that in patients with COVID-19, the cGAS-MITA/STING pathway is critical to the type I IFN immunopathology of extrapulmonary complications in lung endothelial cells after mtDNA release [11, 154, 155]. This evidence concerns the gene STING1 and COVID-19.